Heparin allergy & Heparin intolerance (IE HIT)
Use it with caution in patients with liver dysfunction. Decrease the dose to half of the normal dosing.
No adverse effect on patients with renal dysfunction.
Weight of patient: calculate bolus dose and infusion dose before the start of the procedure
Alaris pump & tubing
Argatroban 1:1 formulation, i.e. 50 mg in 50 mL vials per Pharmacy
Obtain baseline ACT. Argatroban affects ACT and aPTT similarly to heparin.
Range (the operator will determine the range: 230-250 is the typical range for IR procedures)
Initial dose: 200 mcg/kg bolus
Infusion: Begin at 1-2 mcg/kg/min if normal liver function; half the dose if abnormal
Monitor ACT 5-10 minutes after the initial bolus and start of infusion; then monitor ACT every 30 minutes while Argatroban is infusing.
ACT within range: continue infusion at the current rate (i.e. 2 mcg/kg/min if normal liver function).
ACT low: increase rate by doubling infusion dose (i.e. 4 mcg/kg/min) and re-check ACT in 30 minutes.
ACT high: decrease rate by cutting the dose in half (i.e. 1 mcg/kg/min) and re-check ACT in 30 minutes.
The provider can order bolus in Epic.
It is not through the Argatroban infusion order set when an Argatroban infusion is not required.
There is a separate one-time order for a bolus from the Argatroban bottle.
Initial bolus: 250-350 mcg/kg x1 (per provider order). Frequent ACTs monitoring is required.
Additional bolus: 150 mcg/kg per additional dose.
Argatroban package insert. SmithKline Beecham. 2009.
MS Khaja, E. Mathes, WE Saad. Chapter 15- Hematologic Disorders. Patient Care in Vascular & Interventional Radiology. P. Waybill and D. Brown (Eds). Fairfax, VA; SIR 2017.